Nasdaq

Lyra Therapeutics, Inc. Announces Definitive Agreement for Registered Direct Offering and Private Placement of Common Stock and Warrants

Lyra Therapeutics, Inc. has announced a definitive agreement to sell 423,372 shares of common stock and associated private placement warrants through a registered direct offering priced at $11.81 per ...
Business Wire

Enveric Biosciences Announces Closing of $8 Million Registered Direct and Private Placement Offerings, Priced at a Premium to Market Under Nasdaq Rules

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company ...
Seeking Alpha

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

LEXINGTON, Mass., July 2, 2025 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, ...
Business Wire

InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord ...
Morningstar

Largo Announces Reliance on Financial Hardship Exemption in Connection With Registered Direct Offering and Private Placement

Largo Inc. (“Largo” or the “Company”) (TSX: LGO) (NASDAQ: LGO) is pleased to announce further details in connection with the binding term sheet entered into with the senior lenders (“Lenders”) to ...
Nasdaq

60 Degrees Pharmaceuticals, Inc. Closes Registered Direct Offering and Concurrent Private Placement Raising Approximately $1.075 Million

60 Degrees Pharmaceuticals closed a direct stock offering, raising approximately $1.075 million for working capital and corporate purposes. 60 Degrees Pharmaceuticals, Inc. has completed a registered ...